ProfileGDS4718 / 1563154_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 16% 19% 16% 22% 18% 10% 11% 20% 15% 20% 15% 19% 15% 13% 16% 18% 16% 12% 11% 12% 15% 15% 21% 21% 14% 20% 19% 9% 18% 14% 7% 10% 16% 17% 8% 17% 17% 19% 21% 16% 23% 15% 13% 18% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.020816
GSM549102patient 115, normal, homogenized [OPG study]4.1036219
GSM549104patient 119, normal, homogenized [OPG study]3.9717516
GSM549108patient 138, normal, homogenized [OPG study]4.270222
GSM549119patient 077, normal, homogenized [OPG study]4.0751618
GSM549133patient 032, cancer, homogenized [OPG study]3.7260210
GSM549139patient 042, cancer, homogenized [OPG study]3.7899411
GSM549099patient 107, normal, homogenized [OPG study]4.1671220
GSM549109patient 139, normal, homogenized [OPG study]3.9939715
GSM549110patient 046, normal, homogenized [OPG study]4.1501320
GSM549114patient 063, normal, homogenized [OPG study]3.9450915
GSM549122patient 082, normal, homogenized [OPG study]4.1173519
GSM549134patient 033, cancer, homogenized [OPG study]3.9494815
GSM549136patient 036, cancer, homogenized [OPG study]3.8300313
GSM549140patient 044, cancer, homogenized [OPG study]3.9825216
GSM549111patient 047, normal, homogenized [OPG study]4.0381318
GSM549113patient 057, normal, homogenized [OPG study]3.9544916
GSM549132patient 031, cancer, homogenized [OPG study]3.8295412
GSM549137patient 038, cancer, homogenized [OPG study]3.8172611
GSM549142patient 047, cancer, homogenized [OPG study]3.9129912
GSM549100patient 110, normal, homogenized [OPG study]3.9596215
GSM549107patient 135, normal, homogenized [OPG study]3.9284815
GSM549115patient 068, normal, homogenized [OPG study]4.1242321
GSM549116patient 072, normal, homogenized [OPG study]4.1787621
GSM549120patient 078, normal, homogenized [OPG study]3.9135214
GSM549131patient 030, cancer, homogenized [OPG study]4.097720
GSM549118patient 074, normal, homogenized [OPG study]4.1175219
GSM549129patient 027, cancer, homogenized [OPG study]3.76879
GSM549123patient 088, normal, homogenized [OPG study]4.079118
GSM549124patient 006, cancer, homogenized [OPG study]3.9545114
GSM549126patient 015, cancer, homogenized [OPG study]3.65937
GSM549128patient 025, cancer, homogenized [OPG study]3.7715810
GSM549103patient 117, normal, homogenized [OPG study]4.0217516
GSM549117patient 073, normal, homogenized [OPG study]4.0366317
GSM549138patient 041, cancer, homogenized [OPG study]3.670098
GSM549141patient 045, cancer, homogenized [OPG study]3.9919817
GSM549130patient 028, cancer, homogenized [OPG study]4.0614317
GSM549101patient 111, normal, homogenized [OPG study]4.0989519
GSM549105patient 128, normal, homogenized [OPG study]4.2057921
GSM549106patient 134, normal, homogenized [OPG study]3.9661716
GSM549112patient 048, normal, homogenized [OPG study]4.2515723
GSM549125patient 011, cancer, homogenized [OPG study]3.9815115
GSM549127patient 024, cancer, homogenized [OPG study]3.863513
GSM549135patient 035, cancer, homogenized [OPG study]4.020718